Cited 0 times in Scipus Cited Count

Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection

Authors
Lee, HW | Park, JY | Kim, SG | Tak, WY | Yim, HJ | Jang, BK | Kim, MY | Kim, BI | Lee, JW | Yoon, KT | Cheong, JY  | Kwon, SY | Kim, TY | Bae, SH | Seo, YS | Kwon, JH | Kim, DJ | Kim, JK | Jeong, SW | Myoung, S | Ahn, SH | Han, KH | Soul Study Group
Citation
Clinical gastroenterology and hepatology, 17(13). : 2811-2813.e1, 2019
Journal Title
Clinical gastroenterology and hepatology
ISSN
1542-35651542-7714
Abstract
Hepatitis B virus (HBV) suppression with nucleot(s)ide analogue therapy reduces the risk of hepatic decompensation and hepatocellular carcinoma (HCC) in patients with advanced liver disease.(1) In the present era of potent antiviral therapies, the prognostic significance of the serum HBV DNA level as a biological gradient has substantially diminished: the majority of treated patients achieve virologic suppression.(2,3) After control of viremia, a higher baseline fibrosis level is a useful predictor for disease progression.(4) Few "prospective" studies on the effects of antiviral agents, especially in chronic hepatitis B (CHB) patients with advanced liver disease, have been reported.
DOI
10.1016/j.cgh.2019.01.044
PMID
30731195
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Ajou Authors
정, 재연
Files in This Item:
There are no files associated with this item.
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse